Carecloud vs Sophia Genetics SA
Carecloud is the larger business, with $120m of revenue in fiscal 2025 against $77.3m for Sophia Genetics SA (1.6 times as much). Sophia Genetics SA grew faster (18.6% against 8.7%). Carecloud kept more of each dollar of sales as profit: a net margin of 9.0% against -102.2%. Carecloud carries less debt relative to equity (3.2% against 101.2%).
| Latest fiscal year | CarecloudCCLD, 2025 | Sophia Genetics SASOPH, 2025 |
|---|---|---|
| Revenue | $120m | $77.3m |
| Revenue growth | 8.7% | 18.6% |
| Net income | $10.8m | −$79.0m |
| Operating margin | 9.4% | -91.8% |
| Net margin | 9.0% | -102.2% |
| Return on equity | 19.8% | -110.0% |
| Free cash flow | $23.8m | −$36.5m |
| Cash | — | $70.3m |
| Total debt | $1.9m | $47.7m |
| Debt to equity | 3.2% | 101.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 3,650 | — |
| Market value | $73.3m | $460m |
| Price vs our value range | Below our value range | — |
| Moat score | 33 (Weak) | — |
| Insider trades, 12 months | 0 buys, 1 sales | 1 buys, 150 sales |